BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2011
View Archived Issues
Phase III data on rivaroxaban in subjects with acute coronary syndromes
Read More
Human monoclonal antibodies show anticancer potential in preclinical and clinical settings
Read More
TMED10 gene SNP linked to Alzheimer's disease
Read More
Patrys raises funds to support anticancer pipeline
Read More
Medicis completes acquisition
Read More
U3-1287 combinations assessed in lung and pharynx cancer
Read More
Kowa identifies new cholesterol ester transfer protein inhibitors
Read More
New triterpenoid derivatives prepared by Concert Pharmaceuticals
Read More
Purdue exercises option to commercialize Intermezzo
Read More
Novel GPR119 receptor agonists disclosed by Bristol-Myers Squibb
Read More
Infinity Pharmaceuticals patents novel fatty acid synthase inhibitors
Read More
Zalicus begins phase I study of new Z-160 formulation
Read More
Spectrum Pharmaceuticals files IND with FDA for phosphate-binding agent
Read More
Scientists at Merck & Co. synthesize new fatty-acid amide hydrolase inhibitors
Read More
Belgian university discloses novel Amaryllidaceae isocarbostyryl derivatives for cancer
Read More
New 11-beta-HSD1 inhibitors patented in Korea
Read More
Targacept launches two new clinical studies of TC-5619
Read More
Pfizer finalizes acquisition
Read More
AtheroNova and Maxwell Biotech ratify agreement for AHRO-001
Read More
Oncolytics Biotech reports on Reolysin in pancreatic cancer
Read More
Achillion discloses preliminary proof-of-concept data on ACH-2928 and advances ACH-3102
Read More
Pivotal trial of cobicistat meets primary endpoint
Read More
ViroPharma and Halozyme report topline data from hereditary angioedema study
Read More
Second milestone reached in GenVec/Novartis collaboration
Read More
FDA accepts Cell Therapeutics' resubmission of pixantrone NDA as complete
Read More